312 related articles for article (PubMed ID: 37832550)
21. Two sides of the same coin: stem cells in cancer and regenerative medicine.
Ilmer M; Vykoukal J; Recio Boiles A; Coleman M; Alt E
FASEB J; 2014 Jul; 28(7):2748-61. PubMed ID: 24675364
[TBL] [Abstract][Full Text] [Related]
22. Multi-organ Mapping of Cancer Risk.
Zhu L; Finkelstein D; Gao C; Shi L; Wang Y; López-Terrada D; Wang K; Utley S; Pounds S; Neale G; Ellison D; Onar-Thomas A; Gilbertson RJ
Cell; 2016 Aug; 166(5):1132-1146.e7. PubMed ID: 27565343
[TBL] [Abstract][Full Text] [Related]
23. aCLS cancers: Genomic and epigenetic changes transform the cell of origin of cancer into a tumorigenic pathogen of unicellular organization and lifestyle.
Niculescu VF
Gene; 2020 Feb; 726():144174. PubMed ID: 31647999
[TBL] [Abstract][Full Text] [Related]
24. Direct quantification of in vivo mutagenesis and carcinogenesis using duplex sequencing.
Valentine CC; Young RR; Fielden MR; Kulkarni R; Williams LN; Li T; Minocherhomji S; Salk JJ
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33414-33425. PubMed ID: 33318186
[TBL] [Abstract][Full Text] [Related]
25. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
Lichner Z; Mac-Way F; Yousef GM
Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
[TBL] [Abstract][Full Text] [Related]
26. Modeling dynamics of mutants in heterogeneous stem cell niche.
Shahriyari L; Mahdipour-Shirayeh A
Phys Biol; 2017 Feb; 14(1):016004. PubMed ID: 28102174
[TBL] [Abstract][Full Text] [Related]
27. Clonal approaches to understanding the impact of mutations on hematologic disease development.
Nangalia J; Mitchell E; Green AR
Blood; 2019 Mar; 133(13):1436-1445. PubMed ID: 30728143
[TBL] [Abstract][Full Text] [Related]
28. Chemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine.
Liu K; Yu C; Xie M; Li K; Ding S
Cell Chem Biol; 2016 Aug; 23(8):893-916. PubMed ID: 27524294
[TBL] [Abstract][Full Text] [Related]
29. Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer.
Adams PD; Jasper H; Rudolph KL
Cell Stem Cell; 2015 Jun; 16(6):601-12. PubMed ID: 26046760
[TBL] [Abstract][Full Text] [Related]
30. Expansion of mutant stem cell populations in the human colon.
Bjerknes M
J Theor Biol; 1996 Feb; 178(4):381-5. PubMed ID: 8733477
[TBL] [Abstract][Full Text] [Related]
31. Stem cells: promises versus limitations.
Choumerianou DM; Dimitriou H; Kalmanti M
Tissue Eng Part B Rev; 2008 Mar; 14(1):53-60. PubMed ID: 18454634
[TBL] [Abstract][Full Text] [Related]
32. ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection.
Niwa O; Barcellos-Hoff MH; Globus RK; Harrison JD; Hendry JH; Jacob P; Martin MT; Seed TM; Shay JW; Story MD; Suzuki K; Yamashita S;
Ann ICRP; 2015 Dec; 44(3-4):7-357. PubMed ID: 26637346
[TBL] [Abstract][Full Text] [Related]
33. Mouse Model for Sporadic Mutation of Target Alleles to Understand Tumor Initiation and Progression and Stem Cell Dynamics.
Nguyen TN; Manalo EC; Kawashima TE; Fischer JM
Methods Mol Biol; 2020; 2171():273-284. PubMed ID: 32705649
[TBL] [Abstract][Full Text] [Related]
34. Stem cell sources for regenerative medicine.
Riazi AM; Kwon SY; Stanford WL
Methods Mol Biol; 2009; 482():55-90. PubMed ID: 19089350
[TBL] [Abstract][Full Text] [Related]
35. A probabilistic method for leveraging functional annotations to enhance estimation of the temporal order of pathway mutations during carcinogenesis.
Wang M; Yu T; Liu J; Chen L; Stromberg AJ; Villano JL; Arnold SM; Liu C; Wang C
BMC Bioinformatics; 2019 Dec; 20(1):620. PubMed ID: 31791231
[TBL] [Abstract][Full Text] [Related]
36. Germline mutations: many roles in leukemogenesis.
Chen KZ; Kazi R; Porter CC; Qu CK
Curr Opin Hematol; 2020 Jul; 27(4):288-293. PubMed ID: 32487806
[TBL] [Abstract][Full Text] [Related]
37. State of the art: stem cells in equine regenerative medicine.
Lopez MJ; Jarazo J
Equine Vet J; 2015 Mar; 47(2):145-54. PubMed ID: 24957845
[TBL] [Abstract][Full Text] [Related]
38. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine.
Mizuno H; Tobita M; Uysal AC
Stem Cells; 2012 May; 30(5):804-10. PubMed ID: 22415904
[TBL] [Abstract][Full Text] [Related]
39. Stem cells, regenerative medicine, and animal models of disease.
Steindler DA
ILAR J; 2007; 48(4):323-38. PubMed ID: 17712220
[TBL] [Abstract][Full Text] [Related]
40. Cell Competition in Carcinogenesis.
Madan E; Palma AM; Vudatha V; Trevino JG; Natarajan KN; Winn RA; Won KJ; Graham TA; Drapkin R; McDonald SAC; Fisher PB; Gogna R
Cancer Res; 2022 Dec; 82(24):4487-4496. PubMed ID: 36214625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
